Robotic gynecologic surgery provides surgeons a greater range of motion and precision

Robotic surgeries in healthcare are not new, especially in the field of gynecology. In 2005, Food and Drug Administration (FDA) approved the use of robotic surgery for gynecological procedures. When both medication and non-invasive procedures fail to treat gynecological disorder symptoms, doctors recommend surgery. Robotic Gynecologic Surgery stays the acknowledged and best treatment for most gynecological conditions such as cervical cancer, excessive uterine bleeding, uterine fibroids, and more.

Before robotic surgery, surgeons sometimes used to held cameras in their hands, which means they could shake or gradually move. Now, the specialist can get a 3-D perspective on the activity site and the video is steady all through the process. Control has likewise improved with robotic technology. This allows surgeons to work normally and instinctively which can prompt better outcomes and speed up the process. It also helps to reduce the risk of blood loss and quicker recovery.

Researchers from Purdue University have developed magnetic ‘millirobots’ which can climb slopes, move against a current, and deliver substances to rodent neural tissue with great precision.

The study investigated how the robots – ‘Magnetically Aligned Nanorods In Alginate CapsuleS’ (aka ‘Maniacs’) – could perform as drug delivery vehicles inside the body. It found that, when controlled using a magnetic field, the robots can move against fluid flow, climb slopes and move through neural tissue, such as the spinal cord, to deposit substances at precise locations.

Disease in the central nervous system can be very difficult to treat. Lamar Mair of Weinberg Medical Physics, which partnered with the academics on the study, explained: “Delivering drugs orally or intravenously, for example, to target cancers or neurologic diseases, may affect regions of the body and nervous system that are unrelated to the disease. Targeted drug delivery may lead to improved efficacy and reduced side-effects due to lower off-target dosing.”